Heart Health Heart Disease Palpitations & Arrhythmias What Is Non-Sustained Ventricular Tachycardia (NSVT)? Definition, Symptoms, Causes, and Treatment By Richard N. Fogoros, MD Richard N. Fogoros, MD Facebook LinkedIn Richard N. Fogoros, MD, is a retired professor of medicine and board-certified internal medicine physician and cardiologist. Learn about our editorial process Updated on August 04, 2022 Medically reviewed by Yasmine S. Ali, MD, MSCI Medically reviewed by Yasmine S. Ali, MD, MSCI Facebook LinkedIn Twitter Yasmine S. Ali, MD, MSCI, is a board-certified preventive cardiologist and lipidologist. Dr. Ali is also an award-winning writer. Learn about our Medical Expert Board Print Table of Contents View All Table of Contents Symptoms Causes Diagnosis Treatment Prevention Frequently Asked Questions Non-sustained ventricular tachycardia (NSVT, or nonsustained V-tach) is an abnormal heart rhythm that starts in the ventricles, which are the lower chambers of the heart. It occurs as three or more consecutive heartbeats at a rate of more than 100 beats per minute and lasts for less than 30 seconds. Because it does not persist, NSVT is not considered as dangerous as sustained ventricular tachycardia (SVT), which lasts more than 30 seconds. In fact, while not true for everyone, non-sustained VT may turn out to be completely harmless in some people. This article reviews the possible symptoms and causes of NSVT, as well as how it is diagnosed. You'll also learn how this type of abnormal heart rhythm (or arrhythmia) is treated, and when you should seek medical attention. NSVT Symptoms and Signs NSVT is defined as an episode of ventricular tachycardia that: Involves a heart rate of more than 100 beats per minutePersists for at least three heartbeatsLasts less than 30 seconds Most often, NSVT does not cause any symptoms at all. If it does, palpitations—when one feels a fast or irregular heartbeat—may be the only one. The palpitations may be associated with trouble breathing or chest pain. Occasionally, NSVT can cause light-headedness and/or dizziness. Rarely, loss of consciousness (syncope) may occur. Verywell / JR Bee When to Seek Medical Attention While NSVT can be harmless, it can also be a marker for the development of sustained ventricular arrhythmias and sudden death. It's important to see your healthcare provider if you are experiencing: Fleeting chest painLight-headednessYour heart racing, even if it comes and goes Call 911 or seek emergency care if you are experiencing: Trouble breathingChest pain lasting more than a few minutesChest pain accompanied by other symptoms, like nausea, light-headedness, and/or cold sweats What Is Causing the Pain in Your Chest? NSVT Causes NSVT may be caused by a previously unknown structural heart disease—that is, a condition that alters the anatomy of the heart. It may also stem from an electrical instability within the heart that can eventually lead to even more dangerous arrhythmias, such as ventricular fibrillation. This is when the heart stops beating as it should and begins to quiver instead, causing cardiac arrest. There are also reversible factors that may contribute to the development of PVCs. Structural Heart Disease The kinds of heart disease most commonly associated with NSVT are: Coronary artery disease (CAD): When the blood vessels that supply your heart are narrowed or blocked, which may lead to a heart attack Dilated cardiomyopathy heart failure: When your heart chambers become too large and cannot pump blood properly NSVT is also seen with: Hypertrophic cardiomyopathy: When you have an abnormally thick heart muscle Heart valve disease (especially aortic stenosis and mitral regurgitation): When one or more of your four heart valves malfunction Electrical Instability Sometimes, NSVT is caused by an electrical problem in the heart rather than a structural problem. The most common of these conditions is repetitive monomorphic ventricular tachycardia (RMVT). RMVT is a disorder that almost only occurs in young to middle-age people without structural heart disease. Common symptoms include palpitations and light-headedness. In this disorder, an NSVT episode tends to be triggered by emotional stress or exercise. Reversible Factors Various reversible factors may trigger NSVT, such as: Electrolyte imbalances (e.g., low potassium or low magnesium levels in the blood) Substance use, including cocaine and methamphetamine use Low oxygen level in the bloodstream (hypoxia) A low number of healthy red blood cells in the bloodstream (anemia) Certain non-heart conditions, like thyroid disease How Is It Diagnosed? Because NSVT does not usually produce alarming symptoms, it is typically discovered during an electrocardiogram (ECG) done for another reason. If a person is having symptoms, NSVT may be diagnosed through an ambulatory ECG monitoring system. Heart Rhythm Monitoring Ambulatory ECG systems record the electrical activity of your heart over days, weeks, or even years. This longer monitoring period allows for heart arrhythmias that may come and go, like NSVT, to be detected and recorded. A cardiologist—a physician who treats heart conditions—analyzes the recordings from the ambulatory ECG system for NSVT or another arrhythmia. A Holter monitor is one type of ambulatory ECG system. This lightweight and portable monitor is connected by wires to small discs called electrodes that are taped to your chest. The Holter monitor is worn for 24 to 48 hours or longer and records your heart rhythm continuously. Additional Testing If NSVT is diagnosed, your healthcare provider will do further testing to determine if any reversible factors are present. For example, in addition to a medical history/physical exam, various blood tests like a basic metabolic panel, complete blood count, or thyroid-stimulating hormone (TSH) may be ordered. Your healthcare provider will also want to determine if any underlying heart disease is present. Tests that may be done to check for heart disease include: Exercise stress test Echocardiography Cardiac magnetic resonance imaging (MRI) Coronary angiography If the results from one or more of these tests show that underlying heart disease such as coronary artery disease is present, treatment is directed toward that diagnosis. If no underlying heart disease is found, people may be referred to a heart rhythm specialist called a cardiac electrophysiologist to be evaluated for RMVT and other conditions that can produce this arrhythmia. Non-Sustained VT vs. Sustained VT During the diagnostic process, your healthcare provider will determine whether you have NSVT or SVT. The duration of the arrhythmia is a telling differentiator. Non Sustained VT The arrhythmia lasts less than 30 seconds Doesn't typically cause symptoms Is often harmless May be due to a structural or electrical heart issue May not require treatment if there aren't symptoms Sustained VT The arrhythmia lasts longer than 30 seconds May cause fainting or loss of consciousness Can lead to sudden death Most likely due to a structural heart issue May be treated with an intense shock to reset the heart's rhythm and/or medications NSVT Treatment NSVT treatment depends on the underlying cause of the arrhythmia and whether symptoms are present. If no symptoms are present and there is no underlying heart disease, no treatment—other than periodic follow-up with a healthcare provider—may be necessary. NSVT in people with a healthy heart is usually considered harmless. Medications For those with symptoms from NSVT, beta-blockers, calcium channel blockers, or Pacerone (amiodarone) may be used. Amiodarone is an antiarrhythmic drug—a medicine that works to keep your heart in a regular rhythm. Tambocor (flecainide) and Betapace (sotalol) are also antiarrhythmic drugs, but they are not generally recommended to treat NSVT. This is especially true if the NSVT happens as a result of a heart attack. However, these and other antiarrhythmic drugs may be used in certain cases when someone has severe symptoms and is under the care of an electrophysiologist. Ablation Therapy For people with severe symptoms or those who cannot tolerate or receive no benefit from anti-arrhythmic drugs, ablation therapy may be utilized. This therapy involves the use of heat or cold energy to destroy the part of the heart that is deemed the source of abnormal electrical signals. Ablation therapy is successful at treating NSVT around 80% of the time. Implantable Cardioverter-Defibrillator NSVT poses an increased risk of cardiac arrest and sudden death if it occurs in tandem with coronary artery disease or heart failure. This is especially true in people with hypertrophic cardiomyopathy. With these conditions, the risk is related more to the reduced flow of the blood from the left ventricle (called the ejection fraction) than it is to the presence of NSVT itself. To reduce the risk, an implantable cardioverter-defibrillator (ICD) may be recommended in certain people. An ICD is a battery-operated device placed underneath the skin on your chest. It monitors the rhythm of your heart and delivers mild electrical currents or shocks if the rhythm becomes abnormal. Prevention NSVT cannot be directly prevented, but some heart conditions that cause it can be. To optimize your heart health, it's important to do the following: Take part in at least 150 minutes per week of moderate-intensity physical activity (e.g., brisk walking) or 75 minutes per week of vigorous-intensity physical activity (e.g., running). Eat a diet rich in fruits, vegetables, nuts, whole grains, lean protein, and fish. Minimize intake of trans fats, red meat, processed meats, refined carbohydrates (e.g., pasta and white rice), and sugary drinks. Lose weight if you are overweight or obese. Avoid tobacco use and exposure to secondhand smoke. It's also important to see your healthcare provider for regular check-ups. These appointments are, among other things, to monitor you for high blood pressure, high cholesterol, and type 2 diabetes, all of which can contribute to the development of heart disease. Arrhythmias Healthcare Provider Discussion Guide Get our printable guide for your next healthcare provider's appointment to help you ask the right questions. Download PDF Sign up for our Health Tip of the Day newsletter, and receive daily tips that will help you live your healthiest life. Sign Up You're in! Thank you, {{form.email}}, for signing up. There was an error. Please try again. Summary Ventricular tachycardia is an abnormally fast heartbeat caused by irregular electrical impulses that originate in the heart's lower chambers. Non-sustained ventricular tachycardia is a type that stops by itself within 30 seconds. NSVT may arise in healthy people or in those with significant heart disease. Diagnosis involves the use of heart rhythm tests or monitoring. Other tests may be ordered to help figure out the cause of the ventricular tachycardia. Treatment may not be necessary if there are no symptoms. But some with NSVT will need to address any underlying heart disease and/or alleviate serious symptoms. NSVT is often harmless, but can develop into a more dangerous ventricular arrhythmia and cause sudden death. A Word From Verywell While being diagnosed with NSVT may understandably cause you anxiety, keep in mind that this arrhythmia is common and may occur in healthy people. In other words, while it could be a sign of heart disease, it isn't always. If you or a loved one is diagnosed with NSVT, be sure to see a cardiologist for a careful and detailed heart assessment. You can then move forward with a uniquely tailored treatment plan based on the presence or absence of symptoms or any heart problem. Frequently Asked Questions Can you live a normal life with NSVT? Yes. In some cases, you may not even need treatment. Can NSVT go away on its own? Individual episodes can. Still, it's important that you take the recommended steps to manage whatever condition is causing your NSVT. When should I worry about NSVT? NSVT increases anyone's risk of cardiac arrest and sudden death. If you have an underlying heart condition, your risk is even greater. By strictly adhering to your treatment plan and modifying risk factors, you can feel more confident that you're doing all you can to stay well. Learn More: Types of Heart Disease Can you exercise with NSVT? Yes, in most cases it is OK. However, it's a good idea to speak with your healthcare provider about specifics. 20 Sources Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Marine JE. Nonsustained ventricular tachycardia in the normal heart: risk stratification and management. Card Electrophysiol Clin. 2016 Sep;8(3):525-43. doi:10.1016/j.ccep.2016.04.003 Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society. Circulation. 2018;138(13):e190-e252. doi:10.1016/j.hrthm.2017.10.035 Cronin EM, Bogun FM, Maury P, et al. 2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias. Heart Rhythm. 2020 Jan;17(1):e2-e154. doi:10.1016/j.hrthm.2019.03.002 Lin CY, Chang SL, Chung FP, et al. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts. PLoS One. 2016;11(8):e0160181. doi:10.1371/journal.pone.0160181 Harris P, Lysitsas D. Ventricular arrhythmias and sudden cardiac death. BJA Educ. 2016;16(7):221-229. doi:10.1093/bjaed/mkv056 Jamil HA, Mohammed SA, Gierula J, et al. Prognostic significance of incidental nonsustained ventricular tachycardia detected on pacemaker interrogation. Am J Cardiol. 2019;123(3):409-413. doi:10.1016/j.amjcard.2018.10.040 Hammersley DJ, Halliday BP. Sudden cardiac death prediction in non-ischemic dilated cardiomyopathy: a multiparametric and dynamic approach. Curr Cardiol Rep. 2020;22(9):85. doi:10.1007/s11886-020-01343-9 Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793-2867. doi:10.1093/eurheartj/ehv316 Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142(25):e558–e631. doi:10.1161/CIR.0000000000000937 Wang C, Ju W, Chen H, et al. The clinical and electrophysiological characteristics of nonsustained repetitive monomorphic ventricular tachycardia from the left His‐Purkinje system. Pacing Clin Electrophysiol. 2020;43(10):1149-1155. doi:10.1111/pace.14055 UpToDate. Ventricular tachycardia in the absence of apparent structural heart disease. Kohno R, Abe H, Benditt DG. Ambulatory electrocardiogram monitoring devices for evaluating transient loss of consciousness or other related symptoms. J Arrhythm. 2017 May;33(6):583-589. doi:10.1016/j.joa.2017.04.012 Svendsen JH, Goette A, Dobreanu D, et al. Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Europace. 2012;14(2):294-296. doi:10.1093/europace/eus009 Li X, Yao Y, Chen Z, et al. Thyroid‐stimulating hormone within the normal range and risk of major adverse cardiovascular events in nonischemic dilated cardiomyopathy patients with severe left ventricular dysfunction. Clin Cardiol. 2019;42(1):120-128. doi:10.1002/clc.23117 ScienceDirect. Sustained ventricular tachycardia. Katritsis DG, Zareba W, Camm AJ. Nonsustained ventricular tachycardia. J Am Coll Cardiol. 2012;60(20):1993-2004. doi:10.1016/j.jacc.2011.12.063 Nof E, Stevenson WG, John RM. Catheter ablation for ventricular arrhythmias. Arrhythm Electrophysiol Rev. 2013 Apr;2(1):45–52. doi:10.15420/aer.2013.2.1.45 Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 Sep 10;140(11):e596-e646. doi:10.1161/CIR.0000000000000678 Marine JE. Nonsustained ventricular tachycardia in the normal heart: risk stratification and management. Card Electrophysiol Clin. 2016;8(3):525-543. doi:10.1016/j.ccep.2016.04.003 Marine JE, Shetty V, Chow GV, et al. Prevalence and prognostic significance of exercise-induced nonsustained ventricular tachycardia in asymptomatic volunteers: BLSA (Baltimore Longitudinal Study of Aging). J Am Coll Cardiol. 2013;62(7):595-600. doi:10.1016/j.jacc.2013.05.026 By Richard N. Fogoros, MD Richard N. Fogoros, MD, is a retired professor of medicine and board-certified in internal medicine, clinical cardiology, and clinical electrophysiology. See Our Editorial Process Meet Our Medical Expert Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit